510(k) Report

510(k) · Cleared

Cleared

Ysi Model 2300 Stat Glucose and L-Lactate Analyzer

K891480510(k) TraditionalCleared May 22, 198966-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Yellow Springs Instrument Co., Inc. · CGA Glucose Oxidase, Glucose

Cleared on May 22, 1989 after a 66-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 3 later devices descend from it.

Decided
May 22, 1989
Review
66 days
Class
Class II
Product code
CGA
Recalls
None
Predicates
0

3 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2002: 1 descendant cleared2001: 1 descendant cleared2022: 1 descendant cleared1990200020102020
  1. This deviceK891480 Ysi Model 2300 Stat Glucose and L-Lactate AnalyzerYellow Springs Instrument Co., Inc. · 1989
  2. Descendant · cites it directly · 0 of its ownK203549 Nova Primary Glucose Analyzer SystemNova Biomedical Corporation · 2022
  3. Descendant · cites it directly · 0 of its ownK013938 Irma SL Blood Analysis System Lactate CartridgeDiametrics Medical, Inc. · 2002
  4. Descendant · cites it directly · 0 of its ownK011586 Irma SL Blood Analysis System GL CartridgeDiametrics Medical, Inc. · 2001

Most influential descendants

Showing 3 of 3 · See all
  • K203549Nova Primary Glucose Analyzer SystemNova Biomedical Corporation · 2022 · cites it directly0descendants
  • K013938Irma SL Blood Analysis System Lactate CartridgeDiametrics Medical, Inc. · 2002 · cites it directly0descendants
  • K011586Irma SL Blood Analysis System GL CartridgeDiametrics Medical, Inc. · 2001 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K891480Ysi Model 2300 Stat Glucose and L-Lactate AnalyzerYellow Springs Instrument Co., Inc.1989—
+1K203549Nova Primary Glucose Analyzer SystemNova Biomedical Corporation2022—
+1K013938Irma SL Blood Analysis System Lactate CartridgeDiametrics Medical, Inc.2002—
+1K011586Irma SL Blood Analysis System GL CartridgeDiametrics Medical, Inc.2001—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200110
200210
202210
FIG. 1 — Lineage of K891480, 1989–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGA device

  1. #1 K252488 ABL90 FLEX PLUS Systemscore 12.8 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K203549Nova Primary Glucose Analyzer SystemNova Biomedical Corporation20220
K013938Irma SL Blood Analysis System Lactate CartridgeDiametrics Medical, Inc.20020
K011586Irma SL Blood Analysis System GL CartridgeDiametrics Medical, Inc.20010

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K203549 (Nova Biomedical Corporation, 2022) has gone furthest, with 0 descendants of its own.

How does its category compare?

All CGA devices

CGA Glucose Oxidase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CGA

2in 2024

2007: 72008: 62009: 102010: 82011: 92012: 102013: 32014: 52015: 42016: 42017: 22018: 22019: 22020: 22021: 12022: 12023: 42024: 22026 (partial year): 1
2007high 10 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGA

249in 2023

2007: 122 days median2008: 56 days median2009: 155 days median2010: 122 days median2011: 217 days median2012: 123 days median2013: 441 days median2014: 265 days median2015: 150 days median2016: 157 days median2023: 249 days median
2007high 441 (2013) · low 56 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGA

3in 2023

2007: 22008: 22009: 42010: 62011: 32013: 32014: 22015: 6, 2 Class I2016: 22019: 12023: 3
2007high 6 (2010) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CGA

59in 2025

2007: 292008: 372009: 752010: 1722011: 4232012: 2332013: 1722014: 1222015: 1552016: 362017: 922018: 692019: 1162020: 682021: 482022: 2722023: 1,1412024: 2662025: 59
2007high 1,141 (2023) · low 29 (2007)2025

MAUDE reports naming product code CGA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077122229
2008656237
200910155475
201081226172
201192173423
2012101230233
201334413172
201452652122
201541506 (2)155
20164157236
20172—092
20182—069
20192—1116
20202—068
20211—048
20221—0272
2023424931,141
20242—0266
20250—059
20261—0—
Cite this page

510(k) Report. “K891480: Ysi Model 2300 Stat Glucose and L-Lactate Analyzer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K891480

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026